-

NYSE American to Commence Delisting Proceedings with Respect to the Warrants of 10X Capital Venture Acquisition Corp. III (VCXB WS)

NEW YORK--(BUSINESS WIRE)--NYSE American LLC (“NYSE American” or the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the warrants of 10X Capital Venture Acquisition Corp. III (the “Company”), each whole warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share — ticker symbol VCXB WS — from the NYSE American. Trading in the Company’s warrants will be suspended immediately. Trading in the Company’s Class A ordinary shares — ticker symbol VCXB — and units — ticker symbol VCXB.U — will continue on the NYSE American.

NYSE Regulation staff has determined that the Company’s warrants are no longer suitable for listing pursuant to Section 1001 of the NYSE American Company Guide due to the low trading price of such warrants.

The Company has a right to a review of NYSE Regulation staff’s determination to delist the Company’s warrants by the Listings Qualifications Panel of the Committee for Review of the Board of Directors of the Exchange. The NYSE American will apply to the Securities and Exchange Commission to delist the Company’s warrants upon completion of all applicable procedures, including any appeal by the Company of the NYSE Regulation staff’s decision.

Contacts

Company Contacts:
ir@10xcapital.com

NYSE Contact:
NYSE Communications
PublicRelations-NYSE@ice.com

NYSE Regulation


Release Versions

Contacts

Company Contacts:
ir@10xcapital.com

NYSE Contact:
NYSE Communications
PublicRelations-NYSE@ice.com

More News From NYSE Regulation

NYSE to Commence Delisting Proceedings Against Accendra Health, Inc. (ACH)

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock — ticker symbol ACH —of Accendra Health, Inc. (the “Company”) from the NYSE. Trading in the Company’s common stock will be suspended immediately. NYSE Regulation has determined that the Company’s common stock is no longer suitable for listing based on “abnormally low selling price” levels, pursuant to...

NYSE to Commence Delisting Proceedings with Respect to Warrants of LiveWire Group, Inc. (LVWR WS)

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the warrants (“Warrants”) — ticker symbol LVWR WS — to purchase common stock of LiveWire Group, Inc. (the “Company”) from the NYSE. Trading in these Warrants on the NYSE will be suspended immediately. Trading in the Company’s common stock — ticker symbol LVWR — will continue on the NYSE.NYSE Regulation has determined th...

NYSE American to Commence Delisting Proceedings Against KNOREX Ltd. (KNRX)

NEW YORK--(BUSINESS WIRE)--NYSE American LLC (“NYSE American” or the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the Class A ordinary shares of KNOREX Ltd. (the “Company”) — ticker symbol KNRX — from NYSE American. Trading in the Company’s Class A ordinary shares will be suspended immediately. NYSE Regulation has determined that the Company is no longer suitable for listing pursuant to Section 1003(f)(v) of the NYSE American Com...
Back to Newsroom